VitaNova Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 11, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Market Capitalization	12	5	15	18	3	-
Market Cap Growth	-	-70.00%	-14.80%	488.23%	-	-
Enterprise Value	10	4	14	18	3	-
Last Close Price	1.38	0.54	1.80	9.00	1.53	-
PE Ratio	15.43	5.29	106.54	-	21.44	-
PS Ratio	3.60	1.69	26.30	463.52	24.95	-
PB Ratio	6.21	2.36	14.21	-297.45	-85.58	-
P/TBV Ratio	6.21	2.36	14.21	-	-	-
P/FCF Ratio	-	23.36	-	-	737.34	-
P/OCF Ratio	13.30	23.36	-	-	737.34	-
EV/Sales Ratio	3.24	1.58	24.68	463.65	24.65	-
EV/EBIT Ratio	8.64	3.48	68.50	-	-	-
EV/FCF Ratio	-	21.78	-	-	728.24	-
Debt / Equity Ratio	-	-	0.00	-0.27	-0.35	-
Debt / FCF Ratio	-	-	-	-	2.98	-
Net Debt / Equity Ratio	-0.63	-0.41	-0.56	-0.12	0.31	-
Net Debt / FCF Ratio	-1.35	-4.06	1.57	-0.40	-2.71	-
Asset Turnover	1.76	1.54	0.95	2.39	-	-
Inventory Turnover	8.77	12.27	-	-	-	-
Quick Ratio	4.75	5.90	4.33	0.13	0.40	-
Current Ratio	5.05	6.49	8.71	0.13	0.40	-
Return on Equity (ROE)	50.33%	57.39%	28.27%	-	-	-
Return on Assets (ROA)	41.14%	43.79%	21.39%	-95.14%	-	-
Return on Invested Capital (ROIC)	112.76%	107.25%	68.01%	-	-	-
Return on Capital Employed (ROCE)	64.50%	63.30%	19.50%	40.90%	38.20%	29.80%
Earnings Yield	6.48%	18.90%	0.94%	-0.14%	4.67%	-
FCF Yield	-	4.28%	-2.50%	-0.10%	0.14%	-
Buyback Yield / Dilution	-135.00%	-135.00%	-81.28%	-	-	-